Hemispherian
Hemispherian is a biotechnology firm that formulates new treatments for all kinds of cancer.
Hemispherian is active in the biotechnology, consulting, health care, health diagnostics space based in Nordic Countries, Scandinavia, Europe, Middle East, and Africa (EMEA), founded in 2015.
Its activity falls under biotechnology, consulting, health care, health diagnostics; the profile below is assembled from public directory data.
The business is associated with Nordic Countries, Scandinavia, Europe, Middle East, and Africa (EMEA).
Directory data places it at the Grant stage.
Its team size is recorded as c_00011_00050 employees.
Public records show total funding of about $17.7M.
| Sector | Biotechnology, Consulting, Health Care, Health Diagnostics |
|---|---|
| Headquarters | Nordic Countries, Scandinavia, Europe, Middle East, and Africa (EMEA) |
| Founded | 2015 |
| Employees | c_00011_00050 |
| Stage | grant |
| Total funding | $17,715,113 |
Website: www.hemispherian.com
Browse related
Emails and contact routes are reserved for registered members.
Create a free account
Create a free account